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Rheumatic heart disease 
with triple valve involvement
ABSTRACT
Acute rheumatic fever (ARF) is a postinfectious, nonsuppurative sequela of pharyngeal infection caused by Streptococcus 
pyogenes, or Group A β hemolytic Streptococcus (GABHS). Of the associated symptoms, only damage to the heart’s 
valvular tissue, or rheumatic heart disease (RHD), can become a chronic condition leading to congestive heart failure, 
stroke, endocarditis, and death. ARF is the most common cause of cardiac disease in children in developing countries. A 
joint meeting of the World Health Organization and the International Society estimated that 12 million people in developing 
countries were affected by acute rheumatic fever and rheumatic heart disease, with the majority of these being children. This 
level of morbidity is comparable to developed countries’ in the last century, before an increase in the standard of living and 
the introduction of penicillin. Significant trivalvular disease, involving the mitral, aortic and tricuspid valves, is uncommon. 
Although rare, trivalvular disease has been described in the literature. Clinical and hemodynamic manifestations depend 
on the severity of each lesion. We reported this case because of the rare presentation of an uncommon disorder and to 
highlight the fact that the presence of trivalvular disease can be difficult to diagnose, even for a trained physician.
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Introduction
Acute rheumatic fever (ARF) is a postin-
fectious, nonsuppurative sequela of 
pharyngeal infection caused by Strepto-
coccus pyogenes, or Group A β hemo-
lytic Streptococcus (GABHS). Of the 
associated symptoms, only damage to 
the heart’s valvular tissue, or rheumatic 
heart disease (RHD), can become a 
chronic condition. A joint meeting of the 
World Health Organization estimated 
that 12 million people in developing 
countries were affected by acute rheu-
matic fever and rheumatic heart disea-
se, with the majority of these being chil-
dren. This level of morbidity is compara-
ble to that in developed countries’ in the 
last century, before the introduction of 
penicillin. (1) RHD is the most common 
cause of mitral stenosis (MS) in adults 
in developing countries (2) but it is also 
the most common cause of multivalvu-
lar disease. About 60% of patients with 
rheumatic MS have concurrent mild-
to-moderate aortic insufficiency (AI), 
and 10% of patients with rheumatic MS 
have concurrent severe AI. (3) The pre-
sence of concomitant AI may augment 
the volume of mitral regurgitation (MR) 
flow leading to left ventricle (LV) enlar-
gement. The presence of both severe 
MR and severe AI is poorly tolerated. 
Significant trivalvular disease involving 
mitral, aortic and tricuspid valves is 
uncommon. Although rare, trivalvular 
disease has been described in the lite-
rature. We reported this case because 
of the rare presentation of an uncom-
mon disorder and to highlight the fact 
that the presence of trivalvular disease 
can be difficult to diagnose, even for a 
trained physician.
Case report
A 19-year-old Senegalese female pre-
sented to our Emergency Department 
in April 2013 complaining of dyspno-
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ea and severe hypotension. Her vital 
signs included an undetectable blood 
pressure, heart rate of 115 beats/min 
and oxygen saturation of 100% while 
receiving 9 l/min oxygen via a simple 
face mask. On examination, she had 
severe mental deterioration, heart soun-
ds were dysrhythmic and tachycardic 
but without murmur, bruit or rubs, and 
her lungs demonstrated a diminished 
vesicular murmur bilaterally. Hemoglo-
bin was 11.9 g/dl and hematocrit was 
34.8%. Her 12 lead electrocardiogram 
showed atrial fibrillation with a promi-
nent R and S wave in all leads. Chest 
radiography revealed an extremely large 
heart with a prominent aortic knob and 
four chamber enlargement (figure 1). 
An echocardiography examination and 
a cardiology consultation were arran-
ged. Echocardiography revealed severe 
bilateral atriomegaly, severe MS, con-
centric left ventricle hypertrophy with 
reduced ejection fraction (48%), mild 
AI, severe tricuspid insufficiency, peri-
cardial and pulmonary effusion and a 
thrombus in the left atrium. Following 
the echocardiography examination, the 
patient was given low molecular weight 
heparin (5000 IU) to avoid artery embo-
lization and admitted to the cardiology 
intensive care unit. In the following days 
she underwent triple surgical valve repa-
ir. After surgical reparation of both the 
aortic and mitral valve and substitution 
of the tricuspid valve, the patient expe-
rienced three episodes of paroxysmal 
supraventricular tachycardia. Each epi-
sode ended spontaneously. The patient 
was immediately treated with high doses 
of diuretics (furosemide 160 mg per day 
and potassium canrenoate 50 mg per 
day), oral anticoagulant (acenocouma-
rol 4 mg per day), nitrates (nitroglycerine 
60 mg per day) and carbonic anhydrase 
inhibitor (acetazolamide 500 mg per 
day). Two months after surgery, echo-
cardiography demonstrated the absen-
ce of tricuspid insufficiency, mild AI, mild 
mitral insufficiency, normalization of left 
ventricular function with an ejection frac-
tion of 55%. Final oral therapy included 
diuretics (furosemide 75 mg per day 
and potassium canrenoate 25 mg per 
day), ACE inhibitor (ramipril 5 mg per 
day), beta blocker (bisoprolol 1.25 mg 
per day), oral anticoagulant (acenocou-
marol 1 mg per day) and proton pump 
inhibitor (omeprazole 20 mg per day).
Discussion
Pathophysiology
The role of GABHS infection as an initial 
event is clear, and has been supported 
by outbreaks of ARF following pharyn-
gitis, as well as rising antistreptococcal 
antibodies in patients with ARF. (4) ARF 
is believed to be an autoimmune reac-
tion to GABHS infection. In 1945 anti-
cardiac autoantibodies were identified. 
These antibodies could damage host 
tissue without the continued presence 
of streptococci. In 1962, cross-reacti-
vity between human heart tissue and 
GABHS was demonstrated. This cross-
reactivity is believed to occur through 
molecular mimicry: in ARF and RHD, 
the foreign antigen is the M-protein and 
it cross reacts with cardiac myosin. 
Although all four heart valves can be 
involved in rheumatic carditis, there is 
marked predominance of mitral valve 
involvement. The reason for this pre-
valence is yet unknown. Once heart 
valves have been damaged, blood is 
allowed to regurgitate. This can cause 
acute congestive heart failure, which 
can be the presenting symptom of ARF. 
Patients that recover from initial rheu-
matic carditis are likely to have perma-
nent valve damage in the form of ste-
nosis or regurgitation. RHD is the most 
common cause of MS. MS typically 
induces a pressure overload in the left 
atrium, which leads to progressive atrial 
dilatation and, finally, to the creation of 
a profibrillatory environment in the left 
atrium that manifests clinically as atrial 
fibrillation. The other main features of 
MS are the development of pulmonary 
hypertension (5) and tricuspid regurgi-
tation (TR). (6) More than one third of 
patients with MS have been reported 
to have at least moderate TR. (7) Atrial 
fibrillation is a common dysrhythmia in 
Figure 1.  Chest radiography demonstrating cardiomegaly.
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patients with MS (8) and predisposes a 
patient to the development of TR.
Diagnosis
The diagnostic criteria for ARF were 
first developed by Jones in 1944 (9) 
and have been modified several times. 
The criteria are divided into Major and 
Minor criteria. Diagnosis is made by the 
presence of either 2 Major or 1 Major 
and 2 Minor criteria, plus evidence of 
recent streptococcal infection, either 
by a pharyngeal swab culture positive 
for GABHS or positive rapid GABHS 
antigen test.
Therapy
Patients with known chronic valvular 
RHD are managed individually accor-
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ding to lesion severity, location, and 
number of valves involved. Nonsurgical 
recommendations include restriction 
of physical exertion in symptomatic 
patients to reduce cardiovascular load 
and prophylactic antibiotics to prevent 
endocarditis. Medical therapy for pati-
ents with MS aims to reduce heart rate 
and decrease blood volume with beta-
blockers, cautious use of oral diuretics, 
and even digoxin if atrial fibrillation is 
present. Significant trivalvular disease 
involving mitral, aortic, and tricuspid 
valves is uncommon. Yet, for those 
presenting with advanced heart failure 
it is recommended that all three valvular 
lesions should be surgically corrected. 
Triple valve replacement is long and 
complex with mortality reported being 
between 20% and 40%. (10) Althou-
gh improved surgical techniques have 
evolved, declining mortality rates, triple 
valve replacement is usually avoided. 
Our patient underwent tricuspidal sub-
stitution and plastic surgery of the mitral 
and aortic valve.
Conclusion
RHD is an uncommon pathology in 
developed countries, for this reason 
we chose to report what we saw. This 
manuscript aims to remind all clinicians 
that sooner or later they may come 
across a forgotten disease.
